PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 10 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In male albino rats, oral doses (18, 50, 100 mg/kg) significantly increased mount frequency, intromission frequency, prolonged ejaculatory latency, and increased serum testosterone concentrations [PMID:16281088].
In paroxetine-induced ED male Wistar rats, aqueous stem extract (18, 50, 100 mg/kg) restored selected biomolecules in penile and testicular tissues, similar to sildenafil citrate [PMID:35969364].
Extracts showed inhibitory effects against Trypanosoma brucei [PMID:30325205] and significant antiplasmodial activity against Plasmodium falciparum chloroquine-resistant W2 strain [PMID:12738078].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22306470 (2012) — Ghana's herbal market. · Journal of ethnopharmacology
- 2.PMID: 17988698 (2008) — Monoterpene glycosides isolated from Fadogia agrestis. · Phytochemistry
- 3.PMID: 35969364 (2023) — Fadogia agrestis (Schweinf. Ex Hiern) Stem Extract Restores Selected Biomolecules of Erectile Dysfunction in the Testicular and Penile Tissues of Paroxetine-Treated Wistar Rats. · Reproductive sciences (Thousand Oaks, Calif.)
- 4.PMID: 30325205 (2020) — Glycosides of ursane-type triterpenoid, benzophenone, and iridoid from Vangueria agrestis (Fadogia agrestis) and their anti-infective activities. · Natural product research
- 5.PMID: 16281088 (2005) — Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats.